---
source: Solstice - Incyte - MSA.FINAL.111425.docx.pdf
type: MSAs-Signed
extracted: 2026-01-19
---

```markdown
# MASTER MARKETING SERVICE AGREEMENT
(U.S.)

This Master Marketing Service Agreement (the “Agreement ”) is entered into as of the date of last signature (the "Effective Date "), by and between Incyte Corporation, itself and on behalf of its Affiliates, with an address of 1801 Augustine Cut-Off, Wilmington, Delaware, 19803, United States (“Incyte”) and Solstice Health Inc., with an address of 234 5th Avenue, Floor 5, New York, New York, 10001, United States ("Company” or “Counterparty”) (each a “Party” and collectively the “Parties”).

WHEREAS, Company is in the business of providing content creation through use of their proprietary Al-driven platform;

WHEREAS, from time to time during the Term (defined herein) of this Agreement, Incyte may desire to engage Company solely to provide access to Incyte for Company's cloud-based solution for generating and reviewing promotional and marketing assets tailored for pharmaceutical industry compliance (such solution, the “Platform” and the provision of such access, the “Services”), and

WHEREAS, Company is willing to perform such Services in accordance with the terms and conditions of this Agreement.

NOW, THEREFORE, in consideration of the mutual covenants expressed herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Incyte and Company hereby agree as follows:

## 1. Definitions

The following defined terms are used throughout this Agreement in addition to definitions contained within specific sections and the SOWs:

"Affiliates” shall mean any entity that directly or indirectly controls, is controlled by, or is under common control with a Party. In this context, “control” shall mean (1) ownership by one entity of greater than fifty percent (50%) of the voting equity of another entity or (2) power of one entity to direct the management or policies of another entity, by contract or otherwise.

"Applicable Law” shall mean any and all federal, state, local, national and regional statutes, laws, and binding regulations, rules, directives, court order, guidance, or any similar instruction of any governmental, regulatory, or quasi-governmental entity having jurisdiction or authority over a party, applicable to a particular activity hereunder and that may be in effect from time to time during the Term of this Agreement, including, but not limited to, to the extent applicable (i) those promulgated by Regulatory Authorities (defined below), including, without limitation, as applicable, cGMP and/or GLP; (ii) Privacy Laws (defined below); (iii) import and export laws, including export control and economic sanctions regulations which prohibit the shipment of United States-origin products and technology to certain restricted countries, entities and individuals; (iv) those governing payments to healthcare providers; (v) anti-bribery and anti-corruption laws pertaining to interactions with government agents, officials and representatives including without limitation the U.S. federal False Claims Act (31 U.S.C. §§ 3729, et seq.), and Anti-Kickback Statute (42 U.S.C. §§ 1320a-7b, et seq.) and similar state or federal laws, and including the U.S. Foreign Corrupt Practices Act (“FCPA”) and U.K. Bribery Act (“Bribery Act"), any implementing legislation under the OECD Convention Against the Bribery of Foreign Government Officials in International Business Transactions (“OECD Convention”), and the anti-corruption and anti- bribery laws of the jurisdictions in which the Company is conducting business on behalf of Sponsor (collectively, "Anti-Corruption Laws"), (vi) where applicable, the Federal Food, Drug and Cosmetic Act, as amended, and the regulations promulgated thereunder (“FDCA”); and (vii) any United States or other country's or jurisdiction's successor or replacement statutes, laws, rules, regulations, ordinances, and directives related to those described herein (hereinafter collectively, “Applicable Law”).

"Change Order” or “CO” shall mean documented change(s) to a Statement of Work.

"Company Materials" shall mean Company's concepts, ideas, models, know-how, software, methodologies, technology, techniques, procedures, management tools, workshops, manuals, macros, data files, inventions, and other intellectual capital and property that Company has developed, created or acquired prior to or independent of performing Services under this Agreement.

"Deliverables” shall mean all Output provided by Company to Incyte pursuant this Agreement and its related SOWs, whether or not patentable, copyrightable, or susceptible to any other form of legal protection, which are made, conceived, reduced to practice or authored by Company, or Company's Personnel, as a result of the performance of Services.

"Government Official” shall mean (a) any officer, employee of a government or any department, agency or instrument of a government; (b) any person acting in an official capacity for or on behalf of a government or any department, agency, or instrument of a government; (c) any officer or employee of a company or business owned in whole or part by a government; (d) any officer or employee of a public international organization such as the World Bank or United Nations; (e) any political party, officer or employee of a political party or any person acting in an official capacity on behalf of a political party; and/or (f) any candidate or relative of any candidate for political office.

"Incyte Data" shall mean all Inputs and all other data, information and materials provided, uploaded, or submitted by Incyte to the Platform.

"Input" means marketing assets, prompts, parameters, and other information that are input to the Platform by Incyte and Incyte's Authorized Users for the purpose of generating Output.

"Output" means output that is generated by the Platform in response to Incyte and Authorized User's Inputs, including reports and feedback about such Inputs, modified versions of such Inputs, or new or additional assets.

"Personal Data” shall have the meaning set out in Privacy Laws and shall include any such information relating to an identified or identifiable natural person, which either Party makes available to the other Party, or otherwise processes for the purpose and under the services of this Agreement. An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as a name, an identification number, location data, an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person.

"Personnel" shall mean any person or entity employed or engaged by Company, including without limitation, its employees, contractors, consultants or agents who may perform Services or otherwise have obligations or rights in connection with this Agreement.

"Privacy Laws" means to the extent applicable, all data protection laws, including, as applicable but not limited to, those specified in the United States Health Insurance Portability and Accountability Act of 1996, as amended from time to time including but not limited to the amendments in Subtitle D of the Health Information Technology for Economic and Clinical Health Act (“HIPAA”); the EU Data Protection Directive (as may be superseded by the General Data Protection Regulation 2016/679 of the European Parliament and of the Council (“GDPR”)), the Swiss data protection legislation, and/or other applicable data protection privacy legislation in force as amended, extended or replaced from time to time and including any binding regulations and codes of practice, (hereinafter collectively, “Privacy Laws").

"Process”, “Processed” and “Processing” shall have the meaning as set out in the Privacy Laws.

"Service" shall have the same meaning as set forth in the Recitals above.

"Statement of Work” or “SOW” shall mean the details of the Service performed, the form of which is attached in the Statement of Work Exhibit in this Agreement.

"Term" shall mean the period from the Effective Date through the expiry or termination of this Agreement as further described below.

## 2. Services

### 2.1 Statement of Work
During the Term and subject to the terms and conditions of this Agreement, Company shall carry out the Services and provide certain Deliverables at the request of Incyte as set forth and described in detail in one or more Statements of Work. Each SOW shall be sequentially numbered and prepared in substantially the form set forth in the Statement of Work Exhibit. Each SOW shall be signed by authorized representatives of each party and each SOW is incorporated herein by reference, and made a part hereof. Each SOW shall contain a brief background section, a detailed description of the Services, including Deliverables, a timeline for performance of the Services, a description of project staffing, a budget or description of fees, and a payment schedule. Nothing in any SOW or any Company supporting proposal or document submitted for payment shall supersede the terms and conditions of this Agreement.

### 2.2 Incyte Policy
Company shall review and, in providing Services and Deliverables, hereby agrees to adhere to any existing written Incyte policy attached to this Agreement and of which Company is made aware, including but not limited to (if applicable), the Code of Business Conduct & Ethics, the Travel & Expense Reimbursement Policy for Third Party Consultants and Vendors, Insider Trading Policy (as may be revised by the Incyte Board of Directors from time to time), Computer Usage and Information Security policies, and site security policies.

### 2.3 Change Order
Each CO shall be effective upon signature by authorized representatives of each party. Such CO shall be made a part of this Agreement upon the effective date of such CO.

### 2.4 Affiliates
Any Affiliate of Incyte or Company that is expressly made a party to an SOW shall be bound by the terms of this Agreement to the same extent as Incyte or Company, as the case may be, with respect to such SOW, and this Agreement may be enforced against such Affiliate in its own name. Where the context requires, any references to "Incyte” or "Company" in this Agreement or in any SOW shall be deemed to include any Affiliate expressly identified in such SOW, as applicable.

### 2.5 Platform
As part of the Services and subject to the terms and conditions of the Agreement, Company will provide Incyte's authorized employee users (each, an “Authorized User") with credentials for the Platform. Subject to the terms and conditions of the Agreement, Company grants to Incyte a non-exclusive, non-sublicensable, and non-transferable right during the term of the applicable SOW (the “SOW Term”) to use the Platform solely in connection with Incyte's internal business operations and to permit Authorized Users to use the Platform solely for Incyte's internal business purposes.

### 2.6 Use Restrictions
Incyte represents and warrants that it shall not and shall not permit or assist anyone else to directly or indirectly: (a) rent, lease, or otherwise permit third parties to use the Services, including the Platform; (b) use the Services, including the Platform, to provide services to third parties (e.g., as a service bureau); (c) disclose the results of any benchmarking of the Services, including the Platform, or use such results for its own competing software development activities, such as to build a product or application that is competitive with any Company products or any third-party LLM; (d) attempt to bypass, circumvent, or disable any technological or security features or measures in the Services, including the Platform; (e) use the Services, including the Platform, in violation of any applicable laws or regulations; (f) reverse engineer, decompile, disassemble, or otherwise attempt to discover the source code, object code, or underlying structure, ideas, or algorithms of the Services, including the Platform, (except to the extent applicable laws specifically prohibit such restriction); (g) modify, translate, or create derivative works based on the Services, including the Platform; (h) copy, rent, lease, distribute, pledge, assign, or otherwise transfer or encumber rights to the Services, including the Platform; (i) remove or otherwise alter any proprietary notices or labels from the Services, including the Platform, or any portion thereof; (j) interfere or attempt to interfere with the proper working of the Services, including the Platform, or any activities conducted on the Services, including the Platform; (k) represent that any Output is human-generated; or (1) “crawl," "scrape," or "spider” any page, data, or portion of or relating to the Services, including the Platform (or any information, data or content made available through the Services, including the Platform), whether through use of manual or automated means. Incyte is solely responsible for all of Incyte's activity in connection with the Services, including the Platform, and all activity associated with the Services' and Platform's user accounts provisioned to Incyte, including but not limited to uploading Incyte Data onto the Platform. Incyte shall use the Services, including the Platform, in compliance with this Agreement and all Applicable Laws in connection with Incyte's use of the Services, including the Platform. Incyte shall not use the Services, including the Platform, in a manner that is harmful, deceptive, threatening, harassing or obscene or that violates any third-party intellectual property, contractual or other proprietary rights.

## 3. Company Obligations

### 3.1 Incyte Policy
Company shall review and, in providing Services and Deliverables, adhere to any existing written Incyte policy attached to this Agreement and of which Company is made aware, including but not limited to (as applicable), insider trading, travel and expense, and/or site security for Incyte facilities.

#### 3.1.1 Market Research Activities
This section shall only apply in the event that an applicable SOW expressly states that any Services involve market research activities.

Company shall ensure that any such market research activities are conducted in accordance with any Incyte policy of which Company is made aware in advance of conducting such Services and with the applicable national self-regulatory code of practice of which Company is a member or which Company is aware. In the event that Company is not a member of a self-regulatory association in a country where market research activities are conducted, Company shall comply with the most current European Pharmaceutical Market Research Association (EphMRA) Code of Conduct.

#### 3.1.2 Sub-contractors/Third Party Vendors
Counterparty may not engage subcontractors or third party vendors to perform or assist Counterparty in the performance of the Services without the prior written approval of Incyte. For clarity, identification of the subcontractor or third party vendors by name and contact information and the relevant Services or assistance in a written signed work order, statement of work or supplemental contract to this Agreement shall constitute approval. For each approved subcontractor or third party vendor, Counterparty shall be responsible and liable for the activities performed by such subcontractor or third party vendor and for ensuring that the subcontractor or third party vendor abides by all applicable terms of this Agreement. For clarity, Counterparty shall not be entitled to enter into any negotiations or contracts for or on behalf of Incyte and shall have no authority to bind Incyte in any way without the prior written approval of Incyte. Notwithstanding the foregoing or anything to the contrary set forth in this Agreement, “subcontractors" and "third party vendors", as those terms are used in this Agreement, shall not include, and the terms related to subcontractors and third party vendors, including this Section 3.1.2 shall not apply to, any outsourced technology vendors, independent contractors (e.g. outsourced copywriters), providers of third-party large language models (LLMs), or other service providers engaged by Company on an enterprise-basis in connection with Company operations (collectively, “Technology Vendors”) (e.g., cloud hosting providers, PEOs or staff augmentation providers), and nothing herein will be deemed to prohibit or limit Company's ability to engage any Technology Vendors.

#### 3.1.3 Transparency
The parties acknowledge and agree that Incyte may be required to comply with certain laws, regulations, or industry association standards requiring disclosure of certain direct or indirect payments or transfers of value to healthcare professionals, healthcare entities and other persons or entities identified in Applicable Laws (“Covered Recipients"). As further described in the Transparency Exhibit to this Agreement, Counterparty agrees, to the extent Counterparty provides payments or other transfers of value to Covered Recipients on behalf of Incyte, that for applicable Services it will provide to Incyte information regarding payments or other transfers of value (including, but not limited to, any compensation, meals, equipment, supplies, services, or travel and lodging expenses) which Counterparty provides to Covered Recipients.

#### 3.1.4 Reporting of Adverse Events and Product Quality Complaints
This Section 3.1.4 shall only apply if an applicable SOW expressly states that adverse event reporting is included in the Services.

In the event Company receives any reports of adverse events, special situations, or product quality complaints involving Incyte products, Company will report such information to Incyte within twenty-four (24) hours of becoming aware of the information. Furthermore, Company agrees to comply with and report adverse events and product quality complaints to Incyte in accordance with the instructions and process set forth in the Guidance for Reporting Adverse Events, Special Situations, & Product Quality Complaints to Incyte (available via https://incyte.com/Report-AEs-PQCs-to-Pharmacovigilance) ("Guidance"), incorporated herein by reference. The terms “adverse event”, “special situation", and “product quality complaint” are defined in the Guidance.

Company will inform the individual or entity who is reporting the adverse event of Incyte's responsibility to collect, follow up, and report on any adverse event described by such individual/entity.

Incyte will be solely responsible for any regulatory reporting obligations that arise from the receipt and processing of adverse event information.

Based on the nature of the Services provided, Incyte may require reconciliation of safety information collected by Company in accordance with the instructions and process set forth in the Guidance. Company shall comply with such requirements if requested by Incyte.

Based on the nature of the Services provided, Incyte may require Company to ensure that all employees, agents, and/or subcontractors involved in the Incyte project/program complete training with respect to the identification and reporting of adverse events, special situations, and product quality complaints, prior to commencing work on the Incyte project/program and at least annually thereafter. Company agrees to comply with such requirements, if requested by Incyte.

#### 3.1.5 Data Protection
The parties acknowledge that data privacy standards and restrictions from Privacy Laws may apply to Services, Deliverables and/or Confidential Information, and the technical and organizational security measures to apply to such are set forth in Exhibit C. Further, as of the Effective Date of this Agreement, the parties acknowledge that Processing of Personal Information will not involve data subjects outside of the United States. In the event Processing of Personal Information will involve Personal Information of data subjects located outside of the United States, if required by Privacy Laws, prior to such Processing, the parties will either amend this Agreement to provide for appropriate data processing terms or enter into a separate data processing agreement which shall then be incorporated into this Agreement by reference.

#### 3.1.6 LLM Providers
Notwithstanding anything to the contrary, Company agrees that it shall not use, and shall not permit any third-party providers of large language models (LLMs) incorporated into the Platform (“Third-Party LLM Providers") to use, and shall contractually require such Third-Party LLM Providers to not use, any Incyte Data to train, fine-tune, or enhance any machine learning, deep learning, or statistical learning algorithms, LLMs, neural networks, or models. Company shall use commercially reasonable measures to implement and maintain appropriate technical and contractual safeguards designed to prevent such use, including without limitation entering into a Zero Data Retention Amendment with OpenAI, L.L.C., as of August 20, 2025 .

## 4. Confidentiality

### 4.1 Confidential Information
By virtue of this Agreement, each party (the “Receiving Party") shall have access to or may learn certain confidential or proprietary technical, business, scientific, strategic, financial, legal (including intellectual property), commercial, regulatory, organizational, and/or operational information and data of the other party (the “Disclosing Party"), including the existence of this Agreement and the terms of any supplemental document, work order, or statement of work, whether disclosed by or on behalf of the Disclosing Party and in any form of disclosure whether or not expressly identified as confidential (so long as such data or information would be reasonably understood to be confidential given the nature of the information or the circumstances surrounding its disclosure, it shall be deemed "Confidential Information" under this Agreement).

The Receiving Party shall, both during the Term of this Agreement and for a period of ten (10) years after expiration or termination of this Agreement, hold the Disclosing Party's Confidential Information in confidence. The Receiving Party shall not make the Disclosing Party's Confidential Information available in any form to any third party or use the Confidential Information for any purpose other than the implementation of this Agreement or the exercise of its rights expressly set forth in this Agreement. Each party shall take all reasonable steps to ensure that the Confidential Information of the other party is not disclosed or distributed to any other individual or entity in violation of the provisions of this Agreement. Each Party shall disclose the Confidential Information only to those employees, directors, officers, representatives, and agents who need to know the Confidential Information for the purpose of this Agreement and who are bound to observe terms and conditions that are consistent with those of this Agreement.

Confidential Information shall not include information which:

*   (a) is or becomes publicly available through no act or omission of the Receiving Party; or
*   (b) was in the Receiving Party's lawful possession prior to the disclosure and had not been obtained from the Disclosing Party; or
*   (c) is lawfully disclosed to the Receiving Party by a third party without restriction on disclosure; or
*   (d) is independently developed by or for the Receiving Party without the use, reference to or reliance upon the Disclosing Party's Confidential Information.

Notwithstanding the foregoing, the Receiving Party shall have the right to disclose (i) the Disclosing Party's Confidential Information to the extent required by Applicable Law; provided, in each case, that the Receiving Party (a) has given prompt advance written notice, if permissible and reasonable under the circumstances, of such requirement to the Disclosing Party, and (b) has reasonably cooperated with the Disclosing Party to pursue reasonable legal remedies to object to such disclosure and/or to maintain the Confidential Information in confidence and (ii) a copy of this Agreement to its legal, financial, or other professional advisors and potential and actual investors and acquirers, in each case subject to confidentiality obligations consistent with those herein, in connection with a bona fide due diligence inquiry for a financing, acquisition, or similar transaction.

### 4.2 Equitable Relief
The Receiving Party acknowledges that money damages may not be a sufficient remedy for the Disclosing Party in the event of any breach of the Confidentiality terms in this Agreement and that each party is entitled to seek specific performance and injunctive or other equitable relief. Such remedy will be in addition to any other available remedies at law or in equity.

## 5. Fees and Payment

### 5.1 Fees

#### 5.1.1 Professional Fees
Fees for Services shall represent fair market value for such Services. The parties agree that costs charged by Company for Services shall be set forth in each SOW and be based on the pricing outlined in the Pricing Card Schedule in this Agreement. Incyte shall not reimburse Company for time spent traveling.

#### 5.1.2 Intentionally omitted

#### 5.1.3 Pass-Through Costs
For any pass-through expenses, Company agrees to invoice Incyte at cost (without mark-up or surcharge) only for those pass-through expenses necessary for the performance of the Services (and not costs typically assumed by independent contractors). All pass-through costs shall be commercially reasonable and comply with Applicable Laws and applicable industry codes, standards and guidelines. All pass-through expenses shall be estimated prior to such expenses being incurred and set forth in each SOW and/or Change Order, as applicable. Company shall maintain and provide Incyte, in a mutually acceptable format, with a complete and accurate accounting of all pass-through expenses incurred. Any pass-through expense in excess of Five Hundred U.S. dollars ($500) shall require advance written approval by Incyte before being incurred (either through an executed SOW, executed Change Order or other writing). For clarity, this Section is intended to address pass-through costs. Nothing herein shall be interpreted to limit Incyte's ability to require appropriate controls, approvals, or documentation with respect to service fees and similar charges under this Agreement provided that any service fees and similar charges set forth in an SOW mutually agreed to and executed by the parties shall be deemed approved.

### 5.2 Taxes
In the event that taxes or duties, of whatever nature, are required to be made or withheld on payments made pursuant to this Agreement by any state, federal, provincial, or foreign government, including, but not limited to, value added tax, Counterparty shall invoice Incyte for the applicable Taxes (defined below), without mark-up as a pass-through expense, collect the Taxes from Incyte and pay the Taxes due on the Services. All such invoices from Counterparty shall indicate the jurisdiction(s) for which Taxes are being collected by Counterparty. Incyte shall pay all sales and use taxes, including all applicable goods and services tax, value added tax, local taxes, applicable duties, electronic delivery taxes, excise taxes, levies and import fees (collectively, “Taxes”) that are imposed by legislation in connection with the provision of Services that are not recoverable by Counterparty. All fees set forth in a SOW are exclusive of Taxes. Where Taxes are paid by Counterparty, Counterparty will invoice Incyte showing the Taxes included. Where any Taxes are paid directly to a tax authority or government by Incyte, Incyte shall not deduct this amount from any amount due Counterparty. The requirements of this provision shall not apply to any employment-related taxes, duties, income taxes, or withholding and shall only apply to Taxes applicable to the Services.

### 5.3 Invoices
All invoices for pass-through expenses shall contain copies of original receipts or other supporting documentation of such expenses. Company shall submit invoices electronically in accordance with the payment terms set forth in each SOW, or within ten (10) business days following the end of each month during which Services were performed, detailing fees and pass-through expenses incurred, and containing the Incyte purchase order number, electronically based on the instructions Incyte provides with the purchase order number provided after the Effective Date.

### 5.4 Payment
Incyte shall pay Company within sixty (60) days of receipt of each undisputed invoice. Additional terms on any Company invoice are not accepted. Unless otherwise noted in an SOW, Incyte shall remit payments to:

Payee:
Mailing Address:
Attn:
Tax ID #:

## 6. Intellectual Property; Ownership

### 6.1 Ownership of Deliverables
As between the parties, all Deliverables shall be the sole and exclusive property of Incyte. Incyte acknowledges that Output is generated automatically by machine learning technology and may be similar to or the same as Output provided to other customers, and no rights to any Output generated, provided, or returned by the Services for or to other customers are granted to Incyte under this Agreement.

### 6.2 Company Materials
To the extent Company incorporates any Company Materials into any Deliverable, Company shall retain exclusive ownership in such Company Materials and Company hereby grants Incyte a non-exclusive, non-transferable, royalty-free, irrevocable, perpetual, worldwide right and license in the Company Materials to use the Company Materials solely as incorporated into the Deliverables and solely in connection with its use of the Deliverables created by Company in connection with the Services. For the avoidance of doubt, the Services and the Platform, and all updates, upgrades, modifications, and improvements to either of the foregoing shall be deemed "Company Materials."

### 6.3 Incyte Data
Incyte hereby grants to Company a non-exclusive, worldwide, sublicensable right to use, copy, store, disclose, transmit, transfer, publicly display, modify, and create derivative works from Incyte Data only as necessary to: (a) provide the Services; (b) derive or generate Usage Data; (c) create and compile Aggregated Data; and (d) as otherwise required by Applicable Laws or as agreed to in writing between the parties. Incyte is solely responsible for the accuracy, quality, integrity, legality, reliability and appropriateness of all Incyte Data. Incyte represents and warrants that (i) it has made all disclosures, provided all notices, and has obtained all rights, consents, and permissions necessary for Company to Process Incyte Data as contemplated by the Agreement without violating or infringing Applicable Laws, third-party rights, or terms or policies that apply to the Incyte Data and (ii) Incyte Data do not contain any of the following categories of sensitive data: (1) social security number, passport number, driver's license number, or similar identifier (or any portion thereof); (2) credit or debit card number (other than the truncated (last four digits) of a credit or debit card), financial information, banking ac-count numbers or passwords; (3) employment, financial, genetic, biometric or health in-formation; (4) racial, ethnic, political or religious affiliation, trade union membership, or information about sexual life or sexual orientation; (5) account passwords, mother's maiden name, or date of birth; (6) criminal history; (7) any other information or combinations of information that falls within the definition of “special categories of data,” “sensitive data" or "sensitive personal information" under any applicable law or regulation relating to privacy or data protection; or (8) personal information of children under the age of 16.

### 6.4 Usage Data; Aggregated Data
Company may Process performance, analytical, or usage data relating to Incyte's access to or use of the Service (“Usage Data") and Incyte Data that has been deidentified or aggregated with other data such that the resulting data no longer reasonably identifies Incyte or a specific individual (“Aggregated Data") for internal business purposes, such as to: (a) track use of Services for billing purposes; (b) provide support for Services; (c) monitor the performance and stability of the Services; (d) prevent or address technical issues with the Services; (e) to improve Services, its other products and services, and to develop new products and services; and (f) for all other lawful business practices, such as analytics, benchmarking, and reports. Feedback, Usage Data, and Aggregated Data will be not be Incyte Data and will be Company's, and not Incyte's, property and Confidential Information.

### 6.5 Third-Party Services
Incyte acknowledges and agrees that the Services may operate on, with or using application programming interfaces (APIs) and/or other services operated or provided by third parties (such as Third-Party LLM Providers) (collectively, “Third-Party Services"), including without limitation through integrations or connectors to such Third- Party Services that are provided by Company. Company is not responsible for the operation of any Third-Party Services nor the availability or operation of the Services to the extent such availability and operation is dependent up-on Third-Party Services. Company does not make any representations or warranties with respect to Third-Party Services or any third-party providers. Incyte agrees that Incyte's use of the Services including Inputs and implementation of Outputs will not breach or violate any applicable Third-Party LLM Provider terms and policies, including without limitation OpenAI's Usage Policies, available at https://openai.com/policies/usage-policies/, or Anthropic's Usage Policy, available at https://www.anthropic.com/legal/aup.

### 6.6 Ownership Rights
As between the parties, notwithstanding anything to the contrary, (a) Incyte shall retain all right, title and interest in and to the Incyte Data and Outputs, including all intellectual property rights therein and (b) Company retains all right, title, and interest in and to (i) the Services, including the Platform, and all software, algorithms, models, code, information, content, products, works, and other intellectual property and technology, and moral rights related thereto, therein or created, used, or provided by Company for the purposes of the Agreement, including any copies and derivative works of the foregoing and any improvements, enhancements, developments and creations during the term or otherwise; and (ii) Usage Data and Aggregated Data.

### 6.7 Restrictions on Use of Marks
Except as necessary to satisfy obligations and responsibilities or exercise its rights expressly set forth under this Agreement and any SOW, neither party shall use the other party's name, trademarks, trade dress, service marks, logos, domain names, other similar marks, or intellectual property, or other data or information for any purpose or in any manner without express written consent.

### 6.8 Feedback
Incyte may (but is not obligated to) provide suggestions, comments or other feedback to Company about the Services and the Platform (“Feedback”) and Company may freely use and exploit such Feedback except to the extent such Feedback contains Incyte Data .

## 7. Representations, Warranties, Covenants and Disclaimers

### 7.1 Company Representations, Warranties and Covenants
Company represents, warrants and covenants to Incyte as follows:

#### 7.1.1 Authority
Company has the full corporate power and authority to enter into this Agreement and perform its obligations hereunder;

#### 7.1.2 No Conflict
Company's execution, delivery and performance of this Agreement does not breach, violate or cause a default under any agreement or instrument to which it is a party or by which it is bound;

#### 7.1.3 Standard of Service
Company and its Personnel shall perform all Services hereunder in a good and professional manner in accordance with standards and practices that are generally accepted in the industry and exercised by other persons engaged in performing similar services, through competent and properly-trained Personnel;

#### 7.1.4 Compliance with Applicable Law
Company and Personnel agree to provide the Services, in compliance with all Applicable Laws, including where applicable (i) the U.S. federal False Claims Act (31 U.S.C. §§ 3729, et seq.) and Anti-Kickback Statute (42 U.S.C. §§ 1320a-7b, et seq.) and similar state or federal laws, and the U.S. Federal Food, Drug and Cosmetic Act, as amended, and the regulations promulgated thereunder (“FDCA”), (ii) import and export laws, including export control and economic sanctions regulations, (iii) anti-bribery and anti-corruption laws pertaining to interactions with, among others, government agents, officials and representatives, including but not limited to the U.S. Foreign Corrupt Practice Act, as amended (15 U.S.C. §§ 78dd-1, et seq.), U.K. Anti-Bribery Act, Canadian Corruption of Foreign Public Officials Act, and the Canadian Criminal Code, (iv) all other laws prohibiting fraud, racketeering, money laundering, and financing terrorism, and (v) those governing payments to healthcare providers.

Accordingly, no part of any consideration paid to Company under this Agreement may be used to make a prohibited payment for the recommending or arranging for the referral of business or the ordering of items or services, and all consideration to be paid by Company to any third party under this Agreement and any SOW hereunder shall have been determined by Company in advance to be for actual Services rendered or items provided by the recipient. Further, Company agrees that it has not, and represents, warrants, and covenants that it, its Affiliates and its and its Affiliates' directors, officers, Personnel, and anyone acting on its behalf, will not, in connection with the performance of this Agreement, directly or indirectly through a third party intermediary, make, promise, authorize, ratify or offer to make, or take any action in furtherance of, any payment or transfer of any money or other thing of value for the purpose of influencing, inducing or rewarding any act, omission or decision to secure an improper advantage; or improperly assisting it in obtaining or retaining business for it or Incyte, or in any way the purpose or effect of public or commercial bribery. Company agrees that it will maintain true, accurate, and complete invoices, reports, statements, books, and other records in connection with this Agreement, and will provide truthful and complete documentation supporting such records at the reasonable request of Incyte. Company further agrees that upon fourteen (14) Business Days prior written notice, Company will permit, during the term of the Agreement and for five years after final payment has been made under the agreement, Incyte's external third- party auditors access at Incyte's sole expense, during Company's regular business hours, and no more than once per calendar year to any relevant invoices, reports, statements, books, and other records of Company, subject to Company's confidentiality obligations to third parties, solely to the extent necessary to verify Company's compliance with the representations and warranties as specified herein.

#### 7.1.5 Ethics Code
Counterparty represents, warrants, and covenants that during the term of this agreement it will continue to maintain a code of ethics and conduct that is designed to prohibit, detect, and address corruption and sets forth (as a non-exhaustive list): (i) that no owners, directors, employees or subcontractors involved in the performance of the services under this Agreement is a Government Official, and Counterparty agrees to make prompt written disclosure to Incyte of any changes to this information during the Term; (ii) that Counterparty shall not utilize or employ any Affiliate, subcontractor that will, or is likely to, directly or indirectly interact with Government Officials without careful due diligence review; (iii) that Counterparty will provide training and distribute relevant materials regarding Counterparty's code of ethics and conduct and policies regarding compliance with Applicable Laws; (iv) that Counterparty shall perform, to the extent required by Applicable Laws, routine monitoring and auditing of its Affiliates, employees and subcontractors reasonably designed to ensure that employees and subcontractors have not engaged in any violations of Applicable Laws in connection with the performance of this Agreement.

#### 7.1.6 No Government Official
Counterparty is not a Governmental Official nor employed by any government agency.

#### 7.1.7 Audit Access
Company further agrees that upon fourteen (14)
